🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06593132
Recruiting Observational

Single Port Endoscopic Breast Conserving Surgery

NCT06593132 · tracked via the Priya Life Science China tracker
Sponsor
Ren,Yu
Phase
Observational
Started
2023-01-01
Last updated
2024-09-19

Condition(s) studied

Breast Conserving SurgeryEndoscopic Surgery

Investigational drug(s) / intervention(s)

endoscopic breast conserving surgery

endoscopic breast conserving surgery: Breast endoscopy technology completes complex surgical operations through small incisions, achieving aesthetically pleasing results while ensuring tumor safety.

Study summary

The center plans to carry out a prospective clinical study of single hole total endoscopic breast conserving surgery for early breast cancer compared with open breast conserving surgery, to provide high-level evidence-based medical evidence for the development of endoscopic breast conserving surgery for early breast cancer.

Eligibility

Sex
FEMALE
Min age
20 Years
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria: 1. Breast cancer confirmed by pathology; 2. Tumor \<5 cm, TNM stage 0-II; 3. Single Port Endoscopic or traditional open surgery; (4)20 to 70 years old female patients. Exclusion Criteria: 1. Bilateral breast cancer; 2. Reconstruction after breast conserving surgery ; 3. Basic information is not complete; 4. Breast conserving surgery was converted to modified radical resection or subcutaneous adenoidectomy.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
the First Affiliated Hospital of Xi'an Jiaotong University Xi'an Shaanxi Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06593132 on ClinicalTrials.gov ↗ ← All trials in China